Our study included the role of Grhl2 in tumor progression in animal models, which was not tested by Cieply et al. We also tested two of the genes regulated by Grhl2, analyzed publically available clinical data to evaluate the correlation between the expression of Grhl2 and outcome in breast cancer patients and checked its expression levels in metastasis tumors from breast cancer patients. Here, GRHL2 is linked to breast cancer.